Skip to main content
. 2019 Nov;7(22):650. doi: 10.21037/atm.2019.10.78

Figure 3.

Figure 3

The ROC curve and RFS rate according to total plasma cfDNA in HBV-related HCC patients. (A) The ROC curve of total plasma cfDNA in HBV-related HCC patients. The ROC area under the curve was 0.6143, and the 95% CI was 0.41 to 0.82; (B) RFS in HCC patients according to the Kaplan-Meier method. The median recurrence times in the low-cfDNA group and the high-cfDNA group were 14.729±0.712 and 9.264±1.22 months (P=0.026), respectively. RFS, recurrence-free survival; cfDNA, cfDNA, circulating cell-free DNA; ROC, receiver operating characteristic; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.